Drug
Opf 110
Opf 110: highest development phase Phase 1, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| OPF-110 NCT07848334 | Phase 1 |
Latest
Follow Opf 110 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.